Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Therapy-induced senescence rewires the melanoma secretome to promote antitumor immune response and augment cell therapies.
Journal: Journal for immunotherapy of cancer
Published: June 30, 2026
CDK4/6 inhibition sensitizes breast cancer to NK cell therapy by inducing immune-interactive surface proteins.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.
Journal: The oncologist
Published: February 16, 2026
Expanding the Understanding of Polymerase Epsilon in Pancreatic Cancer: Immune Checkpoint Inhibitor Response in Polymerase Epsilon P286R-Mutated Metastatic Pancreatic Adenocarcinoma.
Journal: JCO precision oncology
Published: December 10, 2025
Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer Database.
Journal: Annals of hepato-biliary-pancreatic surgery
Published: October 23, 2025
Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With Cisplatin in Patients With Refractory Solid Tumors.
Journal: JCO precision oncology
Published: July 16, 2025
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).
Journal: Cancer research communications
Published: June 06, 2025
Risk Stratification and Contemporary Predictors of Survival in Hepatocellular Carcinoma Treated With Transarterial Radioembolization.
Journal: Gastroenterology research
Published: May 21, 2025
Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosis.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: May 05, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATP.
Journal: Cancer biology & therapy
Published: March 27, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.
Journal: Journal for immunotherapy of cancer
Published: January 03, 2025
Last Updated: 09/26/2026